Poster presented at AMP 2026
Analytical performance and initial clinical validation of a functional ex vivo platform for the prediction of response to immune checkpoint inhibitors in solid tumors
This poster presents analytical performance data for elive Test™, in which automated sectioning of core needle biopsies met all predefined acceptance criteria. In a validation cohort, elive Test predictions were concordant with clinical response to ICI therapy in 89% of patients.